Literature DB >> 12094100

Lung cancer among rock and slag wool production workers.

Kristina Kjaerheim1, Paolo Boffetta, Johnni Hansen, John Cherrie, Jenny Chang-Claude, Ursula Eilber, Gilles Ferro, Karlheinz Guldner, Jørgen H Olsen, Nils Plato, Louise Proud, Rodolfo Saracci, Peter Westerholm, Aage Andersen.   

Abstract

BACKGROUND: Previous cohort studies have found an elevated risk of lung cancer among rock and slag wool (RSW) production workers. The aim of the present study was to investigate the risk of lung cancer associated with exposure to RSW while controlling for other occupational exposures and tobacco smoking.
METHODS: Since 1971, a total of 196 lung cancer cases occurred among men who worked in seven plants in Denmark, Norway, Sweden, and Germany, with start of production between 1937 and 1950. We obtained information on occupational history and extra-occupational factors from either the subject or the next of kin for 133 cases and 513 matched controls. We assessed occupational exposure on the basis of interview data combined with information from expert panels set up in each factory.
RESULTS: For cumulative exposure to RSW assessed with a 15-year lag, the smoking-adjusted odds ratios in the second, third, and fourth quartiles of exposure were 1.3 (95% confidence interval [CI] = 0.7-2.3), 1.0 (CI = 0.5-1.9), and 0.7 (CI = 0.3-1.3). Similar results were obtained when we included only those workers employed for more than 1 year, when we included other indicators of RSW exposure, and after control for co-exposures.
CONCLUSIONS: This study provides no evidence of a carcinogenic effect on the lung of rock and slag wool under exposure circumstances in the production industry during the last four to five decades.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12094100     DOI: 10.1097/00001648-200207000-00013

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  6 in total

Review 1.  Exposure to silicon carbide and cancer risk: a systematic review.

Authors:  Paolo Boffetta; Dana Hashim
Journal:  Int Arch Occup Environ Health       Date:  2016-09-14       Impact factor: 3.015

2.  Occupational exposure to asbestos and man-made vitreous fibres and risk of lung cancer: a multicentre case-control study in Europe.

Authors:  Rafael Carel; Ann C Olsson; David Zaridze; Neonila Szeszenia-Dabrowska; Peter Rudnai; Jolanta Lissowska; Eleonora Fabianova; Adrian Cassidy; Dana Mates; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Joelle Fevotte; Tony Fletcher; Andrea 't Mannetje; Paul Brennan; Paolo Boffetta
Journal:  Occup Environ Med       Date:  2006-10-19       Impact factor: 4.402

3.  A case-control study of lung cancer nested in a cohort of European asphalt workers.

Authors:  Ann Olsson; Hans Kromhout; Michela Agostini; Johnni Hansen; Christina Funch Lassen; Christoffer Johansen; Kristina Kjaerheim; Sverre Langård; Isabelle Stücker; Wolfgang Ahrens; Thomas Behrens; Marja-Liisa Lindbohm; Pirjo Heikkilä; Dick Heederik; Lützen Portengen; Judith Shaham; Gilles Ferro; Frank de Vocht; Igor Burstyn; Paolo Boffetta
Journal:  Environ Health Perspect       Date:  2010-06-09       Impact factor: 9.031

Review 4.  Perspectives on refractory ceramic fiber (RCF) carcinogenicity: comparisons with other fibers.

Authors:  Helmut Greim; Mark J Utell; L Daniel Maxim; Ron Niebo
Journal:  Inhal Toxicol       Date:  2014-09-29       Impact factor: 2.724

Review 5.  The Carcinogenic Effects of Formaldehyde Occupational Exposure: A Systematic Review.

Authors:  Carmela Protano; Giuseppe Buomprisco; Vittoria Cammalleri; Roberta Noemi Pocino; Daniela Marotta; Stefano Simonazzi; Francesca Cardoni; Marta Petyx; Sergio Iavicoli; Matteo Vitali
Journal:  Cancers (Basel)       Date:  2021-12-29       Impact factor: 6.639

6.  LncRNA MCM3AP-AS1 sponges miR-148a to enhance cell invasion and migration in small cell lung cancer.

Authors:  Hua Luo; Yukun Zhang; Guangmei Qin; Bing Jiang; Lili Miao
Journal:  BMC Cancer       Date:  2021-07-16       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.